CD8A and neoplasm: PI3Kδ inhibitors combined with radiotherapy can reverse the immunosuppressive state of the tumor microenvironment by reducing Treg and myeloid-derived suppressor cell (MDSC) infiltration, thereby enhancing CD8+ T cell activity [59,60].